Optogenetic modulation of central nervous system for treating pain
AssigneeOpsin Biotherapeutics, Inc.
InventorsSamarendra Kumar Mohanty, Darryl Narcisse, Robert BENKOWSKI
Life of this patent
Estimating the term…
Loading patent…
AssigneeOpsin Biotherapeutics, Inc.
InventorsSamarendra Kumar Mohanty, Darryl Narcisse, Robert BENKOWSKI
Estimating the term…
This invention relates generally to compositions and methods for modulating cellular activities using multi-characteristic opsin (MCO). Further, the invention provides methods for treating ailments related to activity of the dorsal root ganglia (DRG), anterior cingulate cortex (ACC) or spinal cord including neuropathic pain. Specific embodiments include methods of modulating inhibitory pathways to inhibit chronic neuropathic pain. The methods can use a light sensitive optogenetic actuator with inhibitory neuron specificity. Embodiments also include an optogenetic pain modulator device that can regulate the frequency and intensity of optogenetic stimulation.
An optogenetic stimulation apparatus for use in a method of inhibiting pain by targeting inhibitory cells with an excitatory light-sensitive protein in a subject suffering from pain, the apparatus comprising an optogenetic stimulation device for emitting light and controlling the emission of the light, and a recombinant nucleic acid encoding an excitatory light-sensitive protein, wherein the method comprising steps of:
2-61. (canceled)
A method of inhibiting pain by targeting inhibitory cells with an excitatory light-sensitive protein in a subject suffering from pain, the method comprising steps of:
Dependencies are inferred from the claim text.